Cyclobenzaprine Should Not Be Prescribed for 90 Days
No, cyclobenzaprine (Flexeril) should not be prescribed for a continuous 90-day period. The FDA label explicitly states that cyclobenzaprine "should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available." 1
Duration Limits Based on Evidence
- Maximum recommended duration is 2-3 weeks, as all clinical trials of cyclobenzaprine were 2 weeks or less in duration (with only a single 3-week trial exception) 2
- The FDA indication specifically limits use to acute, painful musculoskeletal conditions, which are "generally of short duration" 1
- There is insufficient evidence for chronic use of any muscle relaxant for musculoskeletal pain 2
Why 90 Days Is Inappropriate
- Prolonged use increases the risk of central nervous system adverse events (relative risk 2.04 compared to placebo), including drowsiness, dizziness, and sedation 2, 3
- The American Geriatrics Society identifies muscle relaxants as potentially inappropriate medications for older adults due to significant sedation risk and anticholinergic effects 3, 4
- Guidelines explicitly state: "Do not continue cyclobenzaprine beyond 2-3 weeks even if symptoms persist" 2
Clinical Algorithm for Duration
Days 1-14: Primary treatment window where efficacy is demonstrated 5, 6
Days 15-21: Maximum extension if absolutely necessary 1
- Reassess need for continued therapy
- Consider alternative diagnoses if no improvement
Beyond 21 days: Discontinue cyclobenzaprine 2
Important Caveats
- A 90-day prescription would be off-label use without supporting evidence and contrary to FDA labeling 1
- If muscle spasm persists beyond 2-3 weeks, the underlying condition requires re-evaluation rather than continued muscle relaxant therapy 2
- The short trial durations in all research studies (maximum 14 days) indicate these agents were never intended for chronic use 2, 5, 6